|
Post by ktim on Jun 20, 2019 12:32:23 GMT -5
I tried to listen to the webcast, unfortunately, it kept cutting off at 3 or 4 minutes in. It could have been my wifi... Anyway, after the collective commentary and a review of the slides, I put in my latest GTC order. The vast majority of the shares I own are at a price of $1.19 or less. Given all the imbued value within Afrezza, International Expansions, Technosphere, and even peripheral, if not direct associations with RLS, plus the realistic probabilities of a growing pipeline, I simply do not see how this doesn't become a $50 per share within 3 years or less. If I were shorting this stock based on the intent to run the company out of business, based in Afrezza, alone - which I am definitively not - I would start getting the pit in my stomach that indicates now is a good time to closeout and ride up. The dealer dealt a card yesterday, in favor of Mannkinds already strong and strengthening hand! You've obviously come to this game fairly recently compared to many of us, but your singing the same tune that the cheer leading crowd have been for several years. It's always the time that shorts must be shaking in their boots and shares about to take off to $40, $50, $100 or whatever other nonsensical round number picked from thin air. Are you actually serious that you can't see any plausible scenario where MNKD doesn't have a market cap of around $14B in 3 years? Or are you simply dealing in hyperbole without actually being concerned at all by reality? Assuming you actually have average cost around $1.19, you have a big advantage over many of us, and I think there is a reasonable chance you'll make some money over the next 3 years, but nowhere near the hyperbolic amount you propose.
|
|
|
Post by pat on Jun 20, 2019 13:45:10 GMT -5
Yes I think the company could be worth $14B in 3 years.
That’s why I keep buying.
Keep selling shorty mcshortbus
|
|
|
Post by markado on Jun 20, 2019 14:57:36 GMT -5
I tried to listen to the webcast, unfortunately, it kept cutting off at 3 or 4 minutes in. It could have been my wifi... Anyway, after the collective commentary and a review of the slides, I put in my latest GTC order. The vast majority of the shares I own are at a price of $1.19 or less. Given all the imbued value within Afrezza, International Expansions, Technosphere, and even peripheral, if not direct associations with RLS, plus the realistic probabilities of a growing pipeline, I simply do not see how this doesn't become a $50 per share within 3 years or less. If I were shorting this stock based on the intent to run the company out of business, based in Afrezza, alone - which I am definitively not - I would start getting the pit in my stomach that indicates now is a good time to closeout and ride up. The dealer dealt a card yesterday, in favor of Mannkinds already strong and strengthening hand! You've obviously come to this game fairly recently compared to many of us, but your singing the same tune that the cheer leading crowd have been for several years. It's always the time that shorts must be shaking in their boots and shares about to take off to $40, $50, $100 or whatever other nonsensical round number picked from thin air. Are you actually serious that you can't see any plausible scenario where MNKD doesn't have a market cap of around $14B in 3 years? Or are you simply dealing in hyperbole without actually being concerned at all by reality? Assuming you actually have average cost around $1.19, you have a big advantage over many of us, and I think there is a reasonable chance you'll make some money over the next 3 years, but nowhere near the hyperbolic amount you propose. Ktim, I'm no cheerleader. I've been in since mid 2015 and suffered my paper losses with many - not at all to the extent of the earliest investors around approval. But, I'm not gauging or banking on MNKDs SP value based solely on Afrezza, alone, either. How about you take your best three year guess, from today, June 20, 2019, and a free steak dinner goes to whoever is closest at the time.. kind of like the price is right... BTW, of course there are numerous ways in which the stock might not reach $50/share, so, maybe we should measure in Market Cap expansion. But, I digress. What's your best guess?
|
|
|
Post by pat on Jun 20, 2019 17:11:00 GMT -5
Are you talking to yourself?
I’m seeing black helicopters again.
|
|
|
Post by swanybuaya on Jun 20, 2019 18:16:03 GMT -5
I didn't hear him say anything about marketing Afrezza.
|
|
|
Post by cedafuntennis on Jun 20, 2019 18:50:45 GMT -5
[/quote]Management just got bonuses and a raise and options. Wouldn't that ordinarily be an indicator of improved sales trends [/quote] That should have been a result of increased sales and retention, not the other way around.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jun 21, 2019 0:38:47 GMT -5
I don't quite understand the part about "not willing to transfer stock in the short term at these prices." I thought they had around 40 million dollars, why would they need to sell stock in order to make the debt payment? Mike said they are looking to recapitalize the company which means they could go to the debt markets and refinance ALL of their outstanding debt including the $5M they will owe at end of August. That's another reason why they put the money in escrow just incase they can't get a deal done by August at least DF will be paid on time. This time without all of the restrictions and covenants. This will cause the stock to go up because MNKD will have flexibility and they can extend the maturities out to 2025 and beyond. Deerfield's deal was for 6 years so a new deal could be the same term. They might stair step the debt with different maturity dates. 2021 is the timeframe for their Revenues (Afrezza & Royalties) to start rolling in.
|
|
|
Post by ktim on Jun 21, 2019 13:25:43 GMT -5
You've obviously come to this game fairly recently compared to many of us, but your singing the same tune that the cheer leading crowd have been for several years. It's always the time that shorts must be shaking in their boots and shares about to take off to $40, $50, $100 or whatever other nonsensical round number picked from thin air. Are you actually serious that you can't see any plausible scenario where MNKD doesn't have a market cap of around $14B in 3 years? Or are you simply dealing in hyperbole without actually being concerned at all by reality? Assuming you actually have average cost around $1.19, you have a big advantage over many of us, and I think there is a reasonable chance you'll make some money over the next 3 years, but nowhere near the hyperbolic amount you propose. Ktim, I'm no cheerleader. I've been in since mid 2015 and suffered my paper losses with many - not at all to the extent of the earliest investors around approval. But, I'm not gauging or banking on MNKDs SP value based solely on Afrezza, alone, either. How about you take your best three year guess, from today, June 20, 2019, and a free steak dinner goes to whoever is closest at the time.. kind of like the price is right... BTW, of course there are numerous ways in which the stock might not reach $50/share, so, maybe we should measure in Market Cap expansion. But, I digress. What's your best guess? The proper bet for me to win the dinner would be to say $49.99. Of course that is still a ridiculous number. Throwing out wild guess numbers really contributes no value to the discussions here if they aren't supported by details of the rationale... so I'll avoid doing that. I would point out that on current trajectory Afrezza sales will still be far away from "blockbuster" status and that Tret would be the only other drug approved for marketing since there isn't any other API even at the first stage of clinical trials yet.
|
|
|
Post by markado on Jun 22, 2019 10:45:04 GMT -5
Ktim, I'm no cheerleader. I've been in since mid 2015 and suffered my paper losses with many - not at all to the extent of the earliest investors around approval. But, I'm not gauging or banking on MNKDs SP value based solely on Afrezza, alone, either. How about you take your best three year guess, from today, June 20, 2019, and a free steak dinner goes to whoever is closest at the time.. kind of like the price is right... BTW, of course there are numerous ways in which the stock might not reach $50/share, so, maybe we should measure in Market Cap expansion. But, I digress. What's your best guess? The proper bet for me to win the dinner would be to say $49.99. Of course that is still a ridiculous number. Throwing out wild guess numbers really contributes no value to the discussions here if they aren't supported by details of the rationale... so I'll avoid doing that. I would point out that on current trajectory Afrezza sales will still be far away from "blockbuster" status and that Tret would be the only other drug approved for marketing since there isn't any other API even at the first stage of clinical trials yet. You almost got me there, ktim. But you would only win, if the stock weren't at $50 or higher. And, yours is a coward's approach. You're not willing to put forth a value, because you seem unwilling to assume any of the current efforts will move forward at greater than a snail's pace. And, that virtually none of them have intrinsic value, let alone the multibillion dollar value of the production facility alone plus the value of Afrezza. Moreover, you misinterpreted my offer. It's the value of the stock relative to your own assessment, not to you just beating me. Regardless, we seem to know where you stand, at the corner of vagueness and ambiguity, so we'll have to wait until you choose to evaluate MNKD on your own terms, to see what you really think.
|
|
|
Post by ktim on Jun 22, 2019 11:27:34 GMT -5
The proper bet for me to win the dinner would be to say $49.99. Of course that is still a ridiculous number. Throwing out wild guess numbers really contributes no value to the discussions here if they aren't supported by details of the rationale... so I'll avoid doing that. I would point out that on current trajectory Afrezza sales will still be far away from "blockbuster" status and that Tret would be the only other drug approved for marketing since there isn't any other API even at the first stage of clinical trials yet. You almost got me there, ktim. But you would only win, if the stock weren't at $50 or higher. And, yours is a coward's approach. You're not willing to put forth a value, because you seem unwilling to assume any of the current efforts will move forward at greater than a snail's pace. And, that virtually none of them have intrinsic value, let alone the multibillion dollar value of the production facility alone plus the value of Afrezza. Moreover, you misinterpreted my offer. It's the value of the stock relative to your own assessment, not to you just beating me. Regardless, we seem to know where you stand, at the corner of vagueness and ambiguity, so we'll have to wait until you choose to evaluate MNKD on your own terms, to see what you really think. It's not cowardice, but rather simple respect for what the board should be about. The problem with me throwing out a number within the context of betting/guessing is that it lends credibility to the notion that guessing (more like wishful thinking probably) is legitimate. Let's say I put forth $3, or $12, or $1 (or whatever, I'm purposely not putting forth a number), you say $50 and someone else says $500. "Oh, wow Mable, look on the discussion board, the average of three long term investors is $184 per share estimate for three years. We'd better get a second mortgage and buy shares." The entire point of my first comment is that throwing out wild speculative (wishful) numbers that aren't backed by anything is not helpful. I'm not going to lend credibility to that. Do you have any contacts in the pharmaceutical business... Who in the heck has given you a notion that the production facility could be sold for multiple billions of dollars? or are you really just making numbers up to fulfill some sort of fantasy you have? It is not worth multiple billions and no one, including MNKD, is claiming it is.
|
|
|
Post by mytakeonit on Jun 22, 2019 12:33:25 GMT -5
ktim - If you feel that way, why did you even respond? I guess you were trying to lend credibility to the game.
But, that's mytakeonit
|
|
|
Post by cretin11 on Jun 22, 2019 15:42:34 GMT -5
Multibillion dollar production facility? If so, let’s sell that ASAP!
|
|